- Home
- FTFT vs BFRI Comparison
FTFT vs BFRI Comparison
Compare FTFT & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- BFRI
- Stock Information
- Founded
- FTFT N/A
- BFRI 1997
- Country
- FTFT United States
- BFRI United States
- Employees
- FTFT N/A
- BFRI N/A
- Industry
- FTFT Business Services
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- BFRI Health Care
- Exchange
- FTFT Nasdaq
- BFRI Nasdaq
- Market Cap
- FTFT 6.2M
- BFRI 8.7M
- IPO Year
- FTFT N/A
- BFRI 2021
- Fundamental
- Price
- FTFT $0.19
- BFRI $0.94
- Analyst Decision
- FTFT
- BFRI Strong Buy
- Analyst Count
- FTFT 0
- BFRI 1
- Target Price
- FTFT N/A
- BFRI $7.00
- AVG Volume (30 Days)
- FTFT 11.9M
- BFRI 77.3K
- Earning Date
- FTFT 04-15-2025
- BFRI 03-21-2025
- Dividend Yield
- FTFT N/A
- BFRI N/A
- EPS Growth
- FTFT N/A
- BFRI N/A
- EPS
- FTFT N/A
- BFRI N/A
- Revenue
- FTFT $18,543,659.00
- BFRI $35,358,000.00
- Revenue This Year
- FTFT N/A
- BFRI $17.69
- Revenue Next Year
- FTFT N/A
- BFRI $19.71
- P/E Ratio
- FTFT N/A
- BFRI N/A
- Revenue Growth
- FTFT N/A
- BFRI 5.17
- 52 Week Low
- FTFT $0.18
- BFRI $0.65
- 52 Week High
- FTFT $1.21
- BFRI $2.43
- Technical
- Relative Strength Index (RSI)
- FTFT 34.34
- BFRI 43.26
- Support Level
- FTFT $0.20
- BFRI $0.86
- Resistance Level
- FTFT $0.25
- BFRI $0.97
- Average True Range (ATR)
- FTFT 0.04
- BFRI 0.07
- MACD
- FTFT -0.00
- BFRI -0.01
- Stochastic Oscillator
- FTFT 1.23
- BFRI 39.39
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.